Lu, H.-L.; Wu, K.-C.; Chen, C.-W.; Weng, H.-K.; Huang, B.-M.; Lin, T.-Y.; Liu, M.-H.; So, E.-C.; Lin, R.-M.; Wang, Y.-K.
Anticancer Effects of Midazolam on Lung and Breast Cancers by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition. Life 2021, 11, 1396.
https://doi.org/10.3390/life11121396
AMA Style
Lu H-L, Wu K-C, Chen C-W, Weng H-K, Huang B-M, Lin T-Y, Liu M-H, So E-C, Lin R-M, Wang Y-K.
Anticancer Effects of Midazolam on Lung and Breast Cancers by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition. Life. 2021; 11(12):1396.
https://doi.org/10.3390/life11121396
Chicago/Turabian Style
Lu, Hsin-Ling, King-Chuen Wu, Char-Wen Chen, Hung-Kai Weng, Bu-Miin Huang, Ting-Yu Lin, Ming-Hsin Liu, Edmund-Cheung So, Ruey-Mo Lin, and Yang-Kao Wang.
2021. "Anticancer Effects of Midazolam on Lung and Breast Cancers by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition" Life 11, no. 12: 1396.
https://doi.org/10.3390/life11121396
APA Style
Lu, H.-L., Wu, K.-C., Chen, C.-W., Weng, H.-K., Huang, B.-M., Lin, T.-Y., Liu, M.-H., So, E.-C., Lin, R.-M., & Wang, Y.-K.
(2021). Anticancer Effects of Midazolam on Lung and Breast Cancers by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition. Life, 11(12), 1396.
https://doi.org/10.3390/life11121396